FDA NDC
LYBALVI
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 65757-652
- Proprietary name
- LYBALVI
- Nonproprietary name
- olanzapine and samidorphan L-malate
- Labeler
- Alkermes, Inc.
- Dosage form
- TABLET, FILM COATED
- Strength
- 10 mg/1
Run it in Rivvi
Which 2027 plans near you dropped or restricted olanzapine and samidorphan L-malate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.